biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases
Trimtech Therapeutics has raised €41M across 2 funding rounds from 10 investors, most recently a Seed round in Jun 2026. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
